- Personal FinanceCompare Online BrokersTop StocksAlternative Investing
- CryptoGet StartedNFTs
XBiotech (NASDAQ:XBIT), Quotes and News Summary
XBiotech (NASDAQ: XBIT)
Earnings
see more| Q3 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2022-11-08 | ||||||
| REV | |||||||
| Q2 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2022-08-19 | ||||||
| REV | |||||||
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
XBiotech Questions & Answers
You can purchase shares of XBiotech (NASDAQ: XBIT) through any online brokerage.
Other companies in XBiotech’s space includes: Impel Pharmaceuticals (NASDAQ:IMPL), Jounce Therapeutics (NASDAQ:JNCE), Adverum Biotechnologies (NASDAQ:ADVM), Celcuity (NASDAQ:CELC) and Immuneering (NASDAQ:IMRX).
The latest price target for XBiotech (NASDAQ: XBIT) was reported by Piper Sandler on Tuesday, April 7, 2020. The analyst firm set a price target for 18.00 expecting XBIT to rise to within 12 months (a possible 242.21% upside). 0 analyst firms have reported ratings in the last year.
The stock price for XBiotech (NASDAQ: XBIT) is $5.26 last updated August 5, 2022, 8:00 PM UTC.
There are no upcoming dividends for XBiotech.
XBiotech’s Q3 earnings are confirmed for Tuesday, November 8, 2022.
There is no upcoming split for XBiotech.
XBiotech is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.